MRI-compatible device firm Biophan Technologies said it has reduced the size of its board of directors from seven to five members to have a majority of independent directors. The move was necessary to satisfy one of the qualifications for listing on a major national stock exchange, according to the West Henrietta, NY-based firm.
Dr. Michael Friebe and Robert Bramson have agreed not to stand for board re-election, Biophan said.
By AuntMinnie.com staff writers
June 15, 2006
Related Reading
Biophan nets financing, May 19, 2006
Biophan adds to advisory board, May 18, 2006
Biophan inks R&D deal with FDA, May 3, 2006
Biophan makes executive moves, April 12, 2006
Siemens, Biophan start talks on IV-MRI, March 30, 2006
Copyright © 2006 AuntMinnie.com
